Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
WAT | US
-1.33
-0.43%
Healthcare
Diagnostics & Research
30/06/2024
24/04/2026
309.87
307.32
315.88
307.32
Waters Corporation a specialty measurement company provides analytical workflow solutions in Asia the Americas and Europe. It operates through two segments Waters and TA. The company designs manufactures sells and services high and ultra-performance liquid chromatography as well as mass spectrometry (MS) technology systems and support products including chromatography columns other consumable products and post-warranty service plans. It also designs manufactures sells and services thermal analysis rheometry and calorimetry instruments; and develops and supplies software-based products that interface with its instruments as well as other manufacturers' instruments. Its MS technology instruments are used in drug discovery and development comprising clinical trial testing the analysis of proteins in disease processes nutritional safety analysis and environmental testing. The company offers thermal analysis rheometry and calorimetry instruments for use in predicting the suitability and stability of fine chemicals pharmaceuticals water polymers metals and viscous liquids for various industrial consumer good and healthcare products as well as for life science research. Its products are used by life science pharmaceutical biochemical industrial nutritional safety environmental academic and governmental customers working in research and development quality assurance and other laboratory applications. Waters Corporation was founded in 1958 and is headquartered in Milford Massachusetts.
View LessLargecap (10B - 200B USD)
Strong Operating Margin (> 25%)
Weakness based on declining price with high volume
Price Below SMA10D
High Short-term Volatility
Weak P/E, and PEG ratio indicator
High Market Beta (> 0.8)
High Debt to Equity (> 0.75)
High Debt to Asset (> 0.45)
Rich in Valuation (Price to Book > 8)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
43.3%1 month
36.4%3 months
41.5%6 months
34.7%34.84
27.62
14.65
1.48
0.47
22.97
7.80
3.65
995.24M
18.39B
18.39B
-
26.70
-5.90
-4.30
54.57
6.65
4.72
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
44.74
Range1M
58.33
Range3M
118.33
Rel. volume
1.16
Price X volume
263.68M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Medpace Holdings Inc | MEDP | Diagnostics & Research | 410.54 | 12.73B | 4.35% | 33.43 | 20.13% |
| Guardant Health Inc | GH | Diagnostics & Research | 88.91 | 10.94B | 1.18% | n/a | -83144.02% |
| RVTY | RVTY | Diagnostics & Research | 86.77 | 10.70B | -0.44% | 74.79 | 50.79% |
| Solventum Corp. | SOLV | Health Information Services | 68.52 | 10.03B | -0.64% | n/a | 311.02% |
| Charles River Laboratories International Inc | CRL | Diagnostics & Research | 169.8 | 8.77B | 1.23% | 23.63 | 76.32% |
| QIAGEN N.V | QGEN | Diagnostics & Research | 38.41 | 8.54B | 1.16% | 122.86 | 41.16% |
| ICON Public Limited Company | ICLR | Diagnostics & Research | 102.17 | 8.46B | -3.92% | 34.54 | 37.38% |
| Bio-Rad Laboratories Inc | BIO | Diagnostics & Research | 287.84 | 7.97B | 2.28% | n/a | 20.54% |
| HealthEquity Inc | HQY | Health Information Services | 82.45 | 7.20B | 6.05% | 73.07 | 53.66% |
| Lantheus Holdings Inc | LNTH | Diagnostics & Research | 84.33 | 5.86B | 1.82% | 19.19 | 60.42% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Avery Dennison Corporation | AVY | Building Products & Equipment | 165.5 | 13.33B | -1.15% | 27.93 | 140.74% |
| Dolby Laboratories Inc | DLB | Media - Diversified | 64.08 | 6.11B | 1.78% | 34.32 | 0.00% |
| FBIN | FBIN | Building Products & Equipment | 41.54 | 5.16B | 0.34% | 25.57 | 130.24% |
| Thor Industries Inc | THO | Recreational Vehicles | 79 | 4.18B | 0.24% | 23.44 | 27.88% |
| Cinemark Holdings Inc | CNK | Media - Diversified | 28.48 | 3.49B | -0.42% | 27.93 | 934.91% |
| VeriFone Systems Inc | PAY | Building Products & Equipment | 27.25 | 3.39B | 0.96% | 102.46 | 2.10% |
| Polaris Industries Inc | PII | Recreational Vehicles | 60.04 | 3.35B | 1.06% | 14.48 | 170.51% |
| LCI Industries | LCII | Recreational Vehicles | 120.01 | 3.06B | -0.45% | 25.82 | 77.66% |
| Harley-Davidson Inc | HOG | Recreational Vehicles | 23.11 | 3.04B | -1.15% | 7.33 | 218.58% |
| Pitney Bowes Inc | PBI | Building Products & Equipment | 15.58 | 2.80B | 1.37% | n/a | -571.93% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 22.97 | 12.67 | Expensive |
| Ent. to Revenue | 7.80 | 44.00 | Cheaper |
| PE Ratio | 34.84 | 40.09 | Par |
| Price to Book | 14.65 | 77.50 | Cheaper |
| Dividend Yield | - | 1.18 | - |
| Std. Deviation (3M) | 41.46 | 59.59 | Lower Risk |
| Debt to Equity | 1.48 | -14.36 | Expensive |
| Debt to Assets | 0.47 | 0.34 | Expensive |
| Market Cap | 18.39B | 13.71B | Market Leader |